Food producers competing to expand liquid food market

Food producers competing to expand liquid food market

FUKUOKA, Japan - A doctor administers nutritious liquid food to a patient at Imajuku Hospital in Fukuoka's Nishi Ward in October.

  • Product Code
  • ILEA001130895
  • Registered date
  • 2008/12/04 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2008 Kyodo News
  • Media size
  • 1303 × 1871 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 463.48(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

    New Year tuna auction in Tokyo

    TOKYO, Japan, Jan. 6 Kyodo - Video shows a bluefin tuna that fetched 207 million yen ($1.3 million) during the year's first auction at the Toyosu fish market in Tokyo on Jan. 5, 2025. (Kyodo) ==Kyodo

      Tuna auction at Wakayama wholesale market

      NACHIKATSUURA, Japan, Jan. 4 Kyodo - Tuna are lined up for the year's first auction at a regional wholesale market in Nachikatsuura, Wakayama Prefecture, western Japan, on Jan. 4, 2025. (Kyodo) ==Kyodo
        CORRECTED: Bread featuring Japan's new banknotes

        CORRECTED: Bread featuring Japan's new banknotes

        A woman shows three slices of bread resembling Japan's new banknotes at a food and sundry goods maker and retailer in Tokyo's Kita Ward on July 2, 2024, on the eve of their issuance. The bread was made by Shibusawa Ippinkan, named after Eiichi Shibusawa (1840-1931), widely known as the "father of Japanese capitalism," and represents (from top to bottom) a 10,000 yen note, a 5,000 yen note and a 1,000 yen note, featuring Shibusawa, educator Umeko Tsuda (1864-1929), and physician and bacteriologist Shibasaburo Kitasato (1853-1931), respectively.
          Guide robot at railroad station in southwestern Japan

          Guide robot at railroad station in southwestern Japan

          Photo taken on Dec. 15, 2023, shows a self-driving guide robot that Nishi-Nippon Railroad Co. introduced at Nishitetsu Fukuoka Tenjin Station in Fukuoka, southwestern Japan, on a trial basis.
            Guide robot at railroad station in southwestern Japan

            Guide robot at railroad station in southwestern Japan

            Photo taken on Dec. 15, 2023, shows a self-driving guide robot that Nishi-Nippon Railroad Co. introduced at Nishitetsu Fukuoka Tenjin Station in Fukuoka, southwestern Japan, on a trial basis.
              Food delivery robot

              Food delivery robot

              A food delivery robot enters an elevator to deliver lunch, snacks and other food in an office building in Tokyo during a media demonstration on Jan. 10, 2023, held a day ahead of a 17-day test operation by East Japan Railway Co. and KDDI Corp.
                U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                    Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                      New coronavirus

                      New coronavirus

                      FUKUOKA, Japan, May 20 Kyodo - A platform for shinkansen bullet trains at JR Hakata Station in Fukuoka is deserted on May 5, 2020, amid continuing worries over the outbreak of the new coronavirus.